Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus

Cannabinoid Ligands Targeting TRP Channels

(2019) Chanté Muller et al.   Frontiers in Molecular Neuroscience

Kynurenic acid/GPR35 axis restricts NLRP3 inflammasome activation and exacerbates colitis in mice with social stress

(2019) Xiao Zheng et al.   BRAIN BEHAVIOR AND IMMUNITY

Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents

(2019) Guo-Hua Bi et al.   ADDICTION BIOLOGY

Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis

(2018) David M. Dolivo et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model

(2018) Xi Jiang et al.   Journal of Neuroinflammation

Kynurenic Acid Protects against Thioacetamide-Induced Liver Injury in Rats

(2018) Sebastian Marciniak et al.   Analytical Cellular Pathology

Effects of Kisspeptin-10 on Hypothalamic Neuropeptides and Neurotransmitters Involved in Appetite Control

(2018) Giustino Orlando et al.   MOLECULES

Anorexigenic effects induced by RVD-hemopressin(α) administration

(2017) Claudio Ferrante et al.   Pharmacological Reports

Cannabinoid type 1 receptor-containing axons innervate NPY/AgRP neurons in the mouse arcuate nucleus

(2017) Yury M. Morozov et al.   Molecular Metabolism

Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge

(2016) Jennifer M. Parrott et al.   Journal of Neuroinflammation

Bisphenol A induces hypothalamic down-regulation of the the cannabinoid receptor 1 and anorexigenic effects in male mice

(2016) Antonio Suglia et al.   PHARMACOLOGICAL RESEARCH

Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents

(2016) Pius S. Fasinu et al.   PHARMACOTHERAPY

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats

(2016) Daniel I Brierley et al.   PSYCHOPHARMACOLOGY

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

(2015) R B Laprairie et al.   BRITISH JOURNAL OF PHARMACOLOGY

Hypothalamic POMC neurons promote cannabinoid-induced feeding

(2015) Marco Koch et al.   NATURE

Molecular Targets of Cannabidiol in Neurological Disorders

(2015) Clementino Ibeas Bih et al.   Neurotherapeutics

The endocannabinoid system and appetite: relevance for food reward

(2014) Gerry Jager et al.   NUTRITION RESEARCH REVIEWS

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

(2014) Ester Aso et al.   Frontiers in Pharmacology

Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?

(2013) Katarzyna Starowicz et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Emerging paradigms in GPCR allostery: implications for drug discovery

(2013) Denise Wootten et al.   NATURE REVIEWS DRUG DISCOVERY

Orexigenic effects of omentin-1 related to decreased CART and CRH gene expression and increased norepinephrine synthesis and release in the hypothalamus

(2013) Luigi Brunetti et al.   PEPTIDES

Peripheral chemerin administration modulates hypothalamic control of feeding

(2013) Luigi Brunetti et al.   PEPTIDES

Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood

(2012) Ana Pocivavsek et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1Receptors

(2012) Mark Bauer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes

(2010) Luciano De Petrocellis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Obestatin inhibits dopamine release in rat hypothalamus

(2010) Luigi Brunetti et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Metabolomic Analysis Identifies Inflammatory and Noninflammatory Metabolic Effects of Genetic Modification in a Mouse Model of Crohn’s Disease

(2010) Hui-Ming Lin et al.   JOURNAL OF PROTEOME RESEARCH

Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors

(2010) Bogna Ignatowska-Jankowska et al.   NEUROSCIENCE LETTERS

Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

(2009) MG Cascio et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis

(2009) Yannick Marchalant et al.   NEUROBIOLOGY OF DISEASE

Neuroendocrine control of food intake

(2008) Elena Valassi et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Glucagon-like peptide 1 (7–36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus

(2008) Luigi Brunetti et al.   PEPTIDES